HighTower Advisors, LLC - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 59 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q3 2023$1,625,000
-31.2%
74,288
+0.3%
0.00%
-40.0%
Q2 2023$2,361,000
+30.6%
74,038
-0.7%
0.01%
+25.0%
Q1 2023$1,808,000
-23.9%
74,538
-0.7%
0.00%
-20.0%
Q4 2022$2,375,000
+12.1%
75,038
-0.0%
0.01%
-16.7%
Q3 2022$2,118,000
+6.2%
75,068
-0.7%
0.01%
+20.0%
Q2 2022$1,994,000
-25.8%
75,568
-0.8%
0.01%
-16.7%
Q1 2022$2,689,000
+13.4%
76,168
+3.6%
0.01%
+20.0%
Q4 2021$2,371,000
+11.1%
73,488
+2.3%
0.01%
-16.7%
Q3 2021$2,134,000
+15.4%
71,8440.0%0.01%
+20.0%
Q2 2021$1,850,000
+102.4%
71,844
+8.0%
0.01%
+66.7%
Q1 2021$914,000
+21.5%
66,544
+46.8%
0.00%0.0%
Q4 2020$752,00045,3250.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q4 2020
NameSharesValueWeighting ↓
BAIN CAPITAL INVESTORS LLC 60,632,356$1,965,701,00023.51%
Affinity Asset Advisors, LLC 225,000$7,295,0002.65%
Perceptive Advisors 10,173,454$329,822,0002.54%
Artal Group S.A. 1,500,000$48,630,0001.32%
Rock Springs Capital Management LP 1,648,435$53,442,0001.24%
RTW INVESTMENTS, LP 666,666$21,613,0000.32%
BOULDER HILL CAPITAL MANAGEMENT LP 8,900$289,0000.28%
EAM Investors, LLC 39,907$1,294,0000.21%
FEDERATED HERMES, INC. 3,113,333$100,934,0000.19%
Alkeon Capital Management 1,909,035$61,891,0000.12%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders